Journal of Chemotherapy

Papers
(The median citation count of Journal of Chemotherapy is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
A systematic review of implications, mechanisms, and stability of in vivo emergent resistance to colistin and tigecycline in Acinetobacter baumannii31
Managing adult patients with infectious diseases in emergency departments: international ID-IRI study23
Compliance with South Africa’s Antimicrobial Resistance National Strategy Framework: are we there yet?22
Effect of a “handshake” stewardship program versus a formulary restriction policy on High-End antibiotic use, expenditure, antibiotic resistance, and patient outcome19
Comparison of lorlatinib, alectinib and brigatinib in ALK inhibitor–naive/untreated ALK-positive advanced non-small-cell lung cancer: a systematic review and network meta-analysis17
Infective endocarditis by Acinetobacter species: a systematic review16
Roseomonasspecies infections in humans: a systematic review13
Infective endocarditis by Enterobacter cloacae: a systematic review and meta-analysis13
Evaluation of efficacy and safety of fosfomycin versus nitrofurantoin for the treatment of uncomplicated lower urinary tract infection (UTI) in women – A systematic review and meta-analysis12
Current treatments for inoperable mesothelioma: indirect comparisons based on individual patient data reconstructed retrospectively from 4 trials12
Activity of ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol and comparators against Gram-negative organisms causing bloodstream infections in Northern Italy (2019–20211
Anti-biofilm activity of dalbavancin against methicillin-resistant Staphylococcus aureus (MRSA) isolated from human bone infection11
Metformin induces myeloma cells necrosis and apoptosis and it is considered for therapeutic use11
Differential effects of C-reactive protein levels on voriconazole metabolism at three age groups in allogeneic hematopoietic cell transplant recipients11
Calcium-oxidative stress signaling axis and casein kinase 1α mediate eryptosis and hemolysis elicited by novel p53 agonist inauhzin10
miR-302a-3p suppresses melanoma cell progression via targeting METTL310
Therapeutic options for COVID-19: a quick review10
Gram-negative bacteria as causative agents of ventilator-associated pneumonia and their respective resistance mechanisms10
A plethora of carbapenem resistance inAcinetobacter baumannii: no end to a long insidious genetic journey10
Urinary tract infection in a human male patient with Staphylococcus pseudintermedius transmission from the family dog10
Epidemiology, prevalence and risk factors for infections in burn patients: results from a regional burn centre’s analysis10
Early 3-day course of remdesivir in vaccinated outpatients with SARS-CoV-2 infection. A success story9
CircRNA_001895 promotes sunitinib resistance of renal cell carcinoma through regulation of apoptosis and DNA damage repair9
Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection9
Dalbavancin for infective endocarditis: a single centre experience9
The efficacy of colistin monotherapy versus combination therapy with other antimicrobials against carbapenem-resistant Acinetobacter baumannii ST2 isolates9
Investigation of anticancer activities of STA-9090 (ganetespib) as a second generation HSP90 inhibitor in Saos-2 osteosarcoma cells9
miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway9
Evaluation of the synergy of ceftazidime/avibactam in combination with colistin, doripenem, levofloxacin, tigecycline, and tobramycin against OXA-48 producing Enterobacterales9
Trabectedin-irinotecan, a potentially promising combination in relapsed desmoplastic small round cell tumor: report of two cases8
Prognostic factors and effect on survival of immune-related adverse events in patients with non-small-cell lung cancer treated with immune checkpoint blockage8
Hypocrellin B triggered sonodynamic therapy reverses multidrug resistance of doxorubicin-resistant SGC7901/ADR cells via down-regulation of P-gp expression8
Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?8
Bacteremia with Staphylococcus pseudintermedius in a 4 month old pediatric oncology patient8
In-vitro activity of fosfomycin against Escherichia coli and Klebsiella pneumoniae bloodstream isolates and frequency of OXA-48, NDM, KPC, VIM, IMP types of carbapenemases 8
MiR-144-3p inhibits the proliferation, migration and invasion of lung adenocargen cancer cells by targeting COL11A18
Influence of plasma methotrexate level and MTHFR genotype in Korean paediatric patients with acute lymphoblastic leukaemia7
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients7
Voriconazole pharmacokinetics in a critically ill patient during extracorporeal membrane oxygenation7
Epidemiology and risk factors for healthcare-associated infections caused by Pseudomonas aeruginosa7
C1q-like 1 is frequently up-regulated in lung adenocarcinoma and contributes to the proliferation and invasion of tumor cells7
Infective endocarditis by Klebsiella species: a systematic review7
Ceftobiprole and pneumonia in adults admitted to the emergency department is it time to assess a new therapeutic algorithm?7
Relationship between renal dysfunction and electrolyte abnormalities in hematopoietic stem cell transplant patients treated with foscarnet7
Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner7
Prognostic significance of sarcopenia and decreased relative dose intensity during the initial two cycles of first-line sunitinib for metastatic renal cell carcinoma7
Performance of capecitabine in novel combination therapies in colorectal cancer7
Community-acquired pneumonia: aetiology, antibiotic resistance and prospects of phage therapy6
Lambert-Eaton myasthenic syndrome (LEMS) in a patient with lung cancer under treatment with pembrolizumab: a case study6
Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center’s experience6
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer6
Exploring metastatic breast cancer treatment changes during COVID-19 pandemic6
Effect of remdesivir on mortality rate and clinical status of COVID-19 patients: a systematic review with meta-analysis6
Application of tumoroids derived from advanced colorectal cancer patients to predict individual response to chemotherapy6
Dissemination of VIM-producingPseudomonas aeruginosaassociated with high-risk clone ST654 in a tertiary and quaternary hospital in Makkah, Saudi Arabia6
Activity of cefiderocol and synergy of novel β-lactam-β-lactamase inhibitor-based combinations against metallo-β-lactamase-producing gram-negative bacilli: insights from a two-year study (2019–2020)5
LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis5
Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS in vitro by targeting RUNX25
Optimization of tigecycline dosage regimen for different infections in the patients with hepatic or renal impairment5
The point prevalence and inappropriateness of antibiotic use at hospitals in Turkey: a systematic review and meta-analysis5
Novel daidzein molecules exhibited anti-prostate cancer activity through nuclear receptor ERβ modulation, in vitro and in vivo studies5
Species distribution and antifungal susceptibilities of bloodstream Candida isolates: a nine-years single center survey5
Prevalence of leukoencephalopathy and its potential cognitive sequelae in cancer patients5
Initial trough concentration may be beneficial in preventing linezolid-induced thrombocytopenia5
Endocarditis in kidney transplant recipients: a systematic review5
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae5
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients5
Evaluation of fosfomycin combined with vancomycin against vancomycin-resistant coagulase negative staphylococci5
Risk of fatigue with PARP inhibitors in cancer patients: a systematic review and meta-analysis of 29 phase II/III randomized controlled trials5
Natural substances to potentiate canonical glioblastoma chemotherapy5
Capecitabine-associated enterocolitis: Narrative literature review of a rare adverse event and a case presentation5
Pediatric impetigo: an expert panel opinion about its main controversies5
Infective endocarditis in patients with liver cirrhosis: a systematic review5
Infective endocarditis by Serratia species: a systematic review5
Looking beyond ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae: in vitro activity of the novel meropenem-vaborbactam in combination with the old fosfomycin4
Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry4
Proinflammatory circulating markers: new players for evaluating asymptomatic acute cardiovascular toxicity in breast cancer treatment4
Anlotinib as a post-third-line therapy for the treatment of advanced nonsmall cell lung cancer4
Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi’s sarcoma: a real-life study4
Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review4
Sorafenib for hepatocellular carcinoma: potential molecular targets and resistance mechanisms4
Comparative incidence of acute kidney injury in patients on vancomycin therapy in combination with cefepime, piperacillin-tazobactam or meropenem4
Negative impact of high body mass index on cetuximab-mediated cellular cytotoxicity against human colon carcinoma cells4
Is pandrug-resistance in A. baumannii a transient phenotype? Epidemiological clues from a 4-year cohort study at a tertiary referral hospital in Greece4
Circ_SETD3 regulates gefitinib sensitivity and tumor progression by miR-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer4
Carbapenem-resistant Klebsiella pneumoniae outbreak in a COVID-19 intensive care unit; a case-control study4
Luteolin suppresses lung cancer progression through targeting the circ_0000190/miR-130a-3p/notch-1 signaling pathway4
Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cells4
Active metronomic vinorelbine schedules decrease plasma interleukin-2 levels in mice with Lewis lung carcinoma4
Outcomes of diagnosed COVID-19 cancer patients: concerning results of a systematic review4
Pharmacodynamics of D-mannose in the prevention of recurrent urinary infections4
Linezolid-related adverse effects in the treatment of rifampicin resistant tuberculosis: a retrospective study4
LncRNA-IQCH-AS1 sensitizes thyroid cancer cells to doxorubicin via modulating the miR-196a-5p/PPP2R1B signalling pathway4
Circulating tumour cells as prognosis predictive markers of neoadjuvant chemotherapy-treated breast cancer patients4
Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey3
Optimization of dosing regimens of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant Staphylococcus aureus in neutropenic patients with cancer by Monte Carlo simul3
Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring3
Intravenous isavuconazole can be administered 5 days-a-week. A possibility suggested by a real-life observation3
Overcoming cisplatin resistance of human lung cancer by sinomenine through targeting the miR-200a-3p-GLS axis3
Circ_0048856 competes with ABCC1 for miR-193a-5p/miR-98-5p binding sites to promote the cisplatin resistance and tumorigenesis in lung cancer3
Correlation of gemcitabine sensitization by Chk1 inhibition with p53 status3
Docetaxel-induced acute myositis: a case report with review of literature3
Daptomycin-based aminoglycoside-sparing therapy for streptococcal endocarditis: a retrospective multicenter study3
Systematic review and meta-analysis of the predictive power of MTHFR polymorphisms for pemetrexed drug efficacy and toxicity in non-small cell lung cancer patients3
Acute kidney injury following colistin treatment in critically-ill patients: may glucocorticoids protect?3
Oral step-down therapy in patients with uncomplicated Staphylococcus aureus primary bacteremia and catheter-related bloodstream infections3
Disseminated fusariosis in immunocompromised children: a case series and review of literature3
Triptolide inhibits T-cell acute lymphoblastic leukaemia by affecting aberrant epigenetic events in the Wnt signalling pathway3
Dalbavancin as chronic antibiotic suppression therapy for left ventricular assist device driveline infection due to methicillin-resistant Staphylococcus aureus: a case report3
High dose methotrexate in adult Egyptian patients with hematological malignancies: impact of ABCB1 3435C > T rs1045642 and MTHFR 677C > T rs1801133 polymorphisms on toxicities and delayed elimin3
Real life experience with ceftolozane/tazobactam therapy for Pseudomonas aeruginosa bacteremia3
In vitro and in vivo comparison of eravacycline- and tigecycline-based combination therapies for tigecycline-resistant Acinetobacter baumannii3
Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant Escherichia coli in female adolescents3
Identification of T cell-related biomarkers for breast cancer based on weighted gene co-expression network analysis3
Effect of HDAC9 inhibition on epithelial-mesenchymal transition in CD133+ prostate cancer cell lines3
MAP7 promotes proliferation and migration of breast cancer cells and reduces the sensitivity of breast cancer cells to paclitaxel3
The tumor microenvironment: shaping cancer progression and treatment response3
Effect of unsymmetrical oligo-phenylene-ethynylene OPE3 against multidrug-resistant bacteria in vitro and in vivo3
Antibiotic usage in hospitalized patients: a one-day point prevalence study3
Antibacterial and antibiofilm activities of ceragenins against Achromobacter species isolated from cystic fibrosis patients3
Recovery of borderline oxacillin-resistant Staphylococcus pseudintermedius (BORSP) from bone and soft tissue of a rheumatoid arthritis patient with severe osteoporosis: transmission from the fa3
Risk of hypertension with anti-VEGF monoclonal antibodies in cancer patients: a systematic review and meta-analysis of 105 phase II/III randomized controlled trials3
Bictegravir/emtricitabine/tenofovir alafenamide combination in the management of kidney transplant patients with HIV receiving immunosuppressants3
Conceptual framework of antibiotic stewardship programs in reducing ESBL-producing Enterobacteriaceae: a systematic review and meta-analysis3
Overexpression of long non-coding RNA urothelial carcinoma associated 1 causes paclitaxel (Taxol) resistance in colorectal cancer cells by promoting glycolysis3
In vitro activity of newer β-lactam/β-lactamase inhibitor combinations, cefiderocol, plazomicin and comparators against carbapenemase-producing Klebsiella pneumoniae<2
Efflux pump effects on Mycobacterium tuberculosis drug resistance2
The role of PK/PD–based strategies to preserve new molecules against multi-drug resistant gram-negative strains2
Cost-effectiveness analysis of pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer2
Frizzled-3 suppression overcomes multidrug chemoresistance by Wnt/β-catenin signaling pathway inhibition in hepatocellular carcinoma cells2
ESBL-producing Escherichia coli and Klebsiella pneumoniae from health-care institutions in Mexico2
Chemotherapeutic effects of MEK kinase inhibitor and BRAF kinase inhibitor on KRAS-mutated human colon cancer cell lines with different microsatellite instability2
Inhibiting effect of p-Coumaric acid on U87MG human glioblastoma cell growth2
Mechanisms and applications of ferroptosis-associated regulators in cancer therapy and drug resistance2
Emergency department care of ABSSSI with dalbavancin infusion, direct discharge, and outpatient telemedicine follow up: a study protocol2
Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy2
Long-term positive effect of an educational antimicrobial stewardship program implemented in an Internal Medicine Department: a prospective analysis and a point prevalence survey on long-term effect2
Amoxicillin-associated Stevens-Johnson syndrome or toxic epidermal necrolysis: systematic review2
Impact of ward pharmacist-led antimicrobial stewardship in intensive care units2
Long-term physico-chemical stability of 5-fluorouracile at standardised rounded doses (SRD) in MyFuser® portable infusion pump2
In vitro killing of multidrug/extensively drug-resistant Pseudomonas aeruginosa by fosfomycin alone or in combination with antipseudomonal antibiotics2
The effect of PARP inhibitors in homologous recombination proficient ovarian cancer: meta-analysis2
A novel polymerase β inhibitor from phage displayed peptide library augments the anti-tumour effects of temozolomide on colorectal cancer2
Current status of systemic therapy in head and neck cancer2
Ceftobiprole and daptomycin concentrations in valve tissue in a patient with mitralic native valve endocarditis2
Analysis of the clinical characteristics of tigecycline-induced hypofibrinogenemia2
Drugs and liver injury: a not to be overlooked binomial in COVID-192
Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin 2
Comparison of first line chemotherapy regimens for advanced soft tissue sarcoma: a network meta-analysis2
Daptomycin for the successful treatment of postoperative methicillin-resistant Staphylococcus aureus empyema: a case report2
Comparisons of effects of SOX and mFOLFOX6 chemotherapy regimens on patients with locally advanced gastric cancer2
Methicillin-resistant Staphylococcus aureus replication in the presence of high (≥32 µg/ml) drug concentration of vancomycin as seen by electron microscopy1
Combination of mTOR inhibitor PP242 and AMPK activator metformin exerts enhanced inhibitory effects on colorectal carcinoma cells in vitro by blocking multiple kinase pathways1
Osimertinib and chemotherapy combination to treat brain metastasis flare and osimertinib resistance by EGFR C797S1
The effectiveness of cetuximab and panitumumab when combined with FOLFIRI in second-line treatment of KRAS wild type metastatic colorectal cancers. Single centre experience1
Class 1, 2 and 3 integrons in clinical Pseudomonas aeruginosa isolated from Tanta University Hospitals, Egypt1
microRNA-143 interferes the EGFR-stimulated glucose metabolism to re-sensitize 5-FU resistant colon cancer cells via targeting hexokinase 21
Effectiveness and safety of a disposable elastomeric continuous infusion pump for outpatient parenteral antimicrobial therapy (OPAT) in a UK setting1
Tumor mutational burden in non-immunotherapy patients with heavily pretreated metastatic breast cancer: long-term outcomes from a single institution1
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis1
Improving therapeutic resistance: beginning with targeting the tumor microenvironment1
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) therapy increases carotid intima-media thickness and plaque score with von Willebrand factor activity elevation in pati1
Recent advances in caspase-3, breast cancer, and traditional Chinese medicine: a review1
The rising problem of hospital antimicrobial resistance and the challenges of antibiotic prescription in Brazil1
Evaluation of the post-antibiotic effectin vivofor the combination of a β-lactam antibiotic and a β-lactamase inhibitor: ceftazidime-avibactam in neutropenic mouse thigh and lung infections1
BR (bendamustine plus rituximab) versus R-CHOP for patients with indolent B-cell lymphomas: a systematic review and Meta-analysis1
Importance of daptomycin dosage on the clinical outcome in liver transplant recipients with vancomycin-resistant enterococci infection1
TPD7 inhibits the non-small cell lung cancer HCC827 cell growth by regulating EGFR signalling pathway1
Intraventricular treatment of paediatric meningitis due to extensively drug-resistant Gram-negative bacteria: two case reports and review of the literature1
Antibiotic resistance in Campylobacter jejuni and Campylobacter coli: significant contribution of an RND type efflux pump in erythromycin 1
DPYDandTYMSpolymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients1
Hydrolytic activity of KPC-producing Klebsiella pneumoniae clinical isolates1
Irreversible Cabozantinib-induced left ventricular systolic dysfunction, a potentially novel observation1
Real world experience on maintenance chemotherapy with gemcitabine in second line setting for advanced non-small cell lung carcinoma1
Depletion of circPDSS1 inhibits ITGA11 production to confer cisplatin sensitivity through miR-515-5p in gastric cancer1
Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samples1
Infective endocarditis by Actinomyces species: a systematic review1
LncRNA DLEU2 contributes to Taxol resistance of gastric cancer cells through regulating the miR-30c-5p-LDHA axis1
BEZ235 reduction of cisplatin resistance on wild-type EGFR non-small cell lung cancer cells1
Transmembrane protein ADAM29 facilitates cell proliferation, invasion and migration in clear cell renal cell carcinoma1
Optimal vancomycin dose in the treatment of Clostridium difficile infection, antimicrobial stewardship initiative1
Evaluation of synergistic activity of plazomicin-based combinations against KPC-producing Klebsiella pneumoniae with complex multidrug resistance phenotypes1
Impact of antibiotic susceptibility reporting on broad spectrum antibiotic use in serratia and morganella bacteremia1
Quality control and consistency evaluation of ceftriaxone sodium for injection1
In vitro susceptibility of carbapenem-resistant Enterobacterales to eravacycline – the first report from Croatia1
Dual targeting Bcl-2 and Bcl-xL augments osteosarcoma response to doxorubicin1
Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma1
RANK pathway in cancer: underlying resistance and therapeutic approaches1
A snapshot survey of antimicrobial susceptibility among respiratory Staphylococcus aureus isolates: focus on ceftaroline1
Combined impact of hypoalbuminemia and pharmacogenomic variants on voriconazole trough concentration: data from a real-life clinical setting in the Chinese population1
A case of spindle cell dominant histiocytic sarcoma showing a complete remission after first-line chemotherapy with doxorubicin and ifosfamide1
Management of antibiotic-resistant Helicobacter pylori infection: current perspective in Iran1
Aminoglycosides’ dosing and monitoring practices in critically ill patients in Quebec hospitals1
Carbapenem-resistant Gram-negative pathogens associated with septic shock: a review of 120 cases1
Comparative in vitro effectiveness of ceftolozane/tazobactam against pediatric gram-negative drug-resistant isolates1
Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents1
PD-1 inhibitors plus chemotherapy as first-line therapy for stage IV ESCC1
Impact of a hospital sepsis management protocol on the selection of empirical antibiotics in infectious disease consultations1
Amikacin-induced acute kidney injury in mechanically ventilated critically ill patients with sepsis1
VEGF single nucleotide polymorphisms predict improved outcome in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy1
Prolonged clinical response with regorafenib administered as second-line therapy in an elderly patient suffering from peritoneal carcinomatosis of colon cancer1
Resveratrol suppresses NSCLC cell growth, invasion and migration by mediating Wnt/β-catenin pathway via downregulating SIX4 and SPHK21
Global status of phenotypic pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates: an updated systematic review and meta-analysis1
Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy1
Is ceftriaxone a suitable option for the empirical treatment of postoperative pleural empyema?1
MTHFR polymorphism as a predictive biomarker for gastrointestinal and hematological toxicity in North Indian adenocarcinoma patients1
An analysis of totally implantable central venous port system infections in an urban tertiary referral center1
Anti-programmed death ligand 1 immunotherapy in patients with limited-stage small cell lung cancer: a real-world exploratory study1
Astaxanthin induces autophagy and apoptosis in murine melanoma B16F10-Nex2 cells and exhibits antitumor activity in vivo1
The BioWipe: a non-invasive method to detect intestinal carriage of multi-drug resistant GRAM-negative bacteria1
Time to reconsider moxifloxacin anti-anaerobic activity?1
0.025317907333374